Literature DB >> 19623040

Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.

Yasuyuki Susa1, Yoshiki Masuda, Hitoshi Imaizumi, Akiyoshi Namiki.   

Abstract

OBJECTIVES: : To determine the relationship between intra-abdominal sepsis-induced high mobility group-box 1 and diaphragm contractile performance and to determine the inhibitory effects of antibodies for high mobility group-box 1 and receptor for advanced glycation end-products on septic peritonitis-induced diaphragmatic dysfunction, lipid peroxidation, and intracellular signal transduction in the rat diaphragm. In animal models of sepsis, production of reactive oxygen species has been shown to elicit diaphragmatic dysfunction. Extracellularly released high mobility group-box 1 can bind to cell surface receptors, such as receptor for advanced glycation end-products, eliciting inflammatory responses that lead to the development of sepsis.
DESIGN: : Prospective laboratory study.
SETTING: : University laboratory.
SUBJECTS: : Wistar rats (n = 186).
INTERVENTIONS: : Intra-abdominal sepsis was induced, using cecal ligation and perforation. In experiment 1, serum and diaphragm homogenates were obtained from sham-operated rats and from cecal ligation and perforation rats at 4-hr intervals postoperatively. In experiment 2, anti-high mobility group-box 1 and anti-receptor for advanced glycation end-products antibodies were administered 4 hrs and 8 hrs after cecal ligation and perforation to determine their effects on cecal ligation and perforation-induced diaphragm dysfunction, reactive oxygen species-related variables, and intracellular signal transduction.
MEASUREMENTS AND MAIN RESULTS: : In experiment 1, cecal ligation and perforation induced serum and diaphragmatic high mobility group-box 1 within 8 hrs postoperatively with a decline in diaphragmatic force generation at 12 hrs after cecal ligation and perforation. In experiment 2, anti-receptor for advanced glycation end-products and anti-high mobility group-box 1 antibodies significantly attenuated cecal ligation and perforation-induced diaphragmatic dysfunction in a dose-related manner. Diaphragmatic malondialdehyde concentration and phosphorylation level of extracellular signal-regulated kinase 1/2 in the groups treated with these antibodies were significantly lower than those in the nontreated group. Anti-receptor for advanced glycation end-products antibody downregulated high mobility group-box 1 expression in the diaphragm during sepsis.
CONCLUSIONS: : Cecal ligation and perforation induces high mobility group-box 1 in the diaphragm and increases serum high mobility group-box 1 level as a late-phase mediator, decreasing contractile performance by high mobility group-box 1 receptor for advanced glycation end-products interaction-mediated reactive oxygen species production. These findings suggested an important role of receptor for advanced glycation end-products-high mobility group-box 1 interaction in diaphragmatic dysfunction induced by lipid peroxidation in rats with intra-abdominal sepsis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19623040     DOI: 10.1097/CCM.0b013e3181a930f7

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Early administration of cisatracurium attenuates sepsis-induced diaphragm dysfunction in rats.

Authors:  Jihong Jiang; Bin Yang; Guangwei Han; Meirong Yang; Shitong Li
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

2.  Deficiency of the novel high mobility group protein HMGXB4 protects against systemic inflammation-induced endotoxemia in mice.

Authors:  Xiangqin He; Kunzhe Dong; Jian Shen; Guoqing Hu; Jinhua Liu; Xiuhua Kang; Liang Wang; Reem T Atawia; Islam Osman; Robert W Caldwell; Meixiang Xiang; Wei Zhang; Zeqi Zheng; Liwu Li; David J R Fulton; Keyu Deng; Hongbo Xin; Jiliang Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

Review 3.  Targeting HMGB1 in inflammation.

Authors:  Huan Yang; Kevin J Tracey
Journal:  Biochim Biophys Acta       Date:  2009-12-03

4.  Senescence-dependent impact of anti-RAGE antibody on endotoxemic liver failure.

Authors:  Angela Kuhla; Mandy Hauke; Kai Sempert; Brigitte Vollmar; Dietmar Zechner
Journal:  Age (Dordr)       Date:  2013-01-15

5.  CK2 phosphorylation of Schistosoma mansoni HMGB1 protein regulates its cellular traffic and secretion but not its DNA transactions.

Authors:  Isabel Caetano de Abreu da Silva; Vitor Coutinho Carneiro; Renata de Moraes Maciel; Rodrigo Furtado Madeiro da Costa; Daniel Rodrigues Furtado; Francisco Meirelles Bastos de Oliveira; Mário Alberto Cardoso da Silva-Neto; Franklin David Rumjanek; Marcelo Rosado Fantappié
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

6.  Muscle dysfunction associated with adjuvant-induced arthritis is prevented by antioxidant treatment.

Authors:  Takashi Yamada; Masami Abe; Jaesik Lee; Daisuke Tatebayashi; Koichi Himori; Keita Kanzaki; Masanobu Wada; Joseph D Bruton; Håkan Westerblad; Johanna T Lanner
Journal:  Skelet Muscle       Date:  2015-07-09       Impact factor: 4.912

7.  Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.

Authors:  Koichi Himori; Masami Abe; Daisuke Tatebayashi; Jaesik Lee; Håkan Westerblad; Johanna T Lanner; Takashi Yamada
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

8.  Therapeutic Effectiveness of Anti-RAGE Antibody Administration in a Rat Model of Crush Injury.

Authors:  Hisatake Matsumoto; Naoya Matsumoto; Junya Shimazaki; Junichiro Nakagawa; Yukio Imamura; Kazuma Yamakawa; Tomoki Yamada; Mitsunori Ikeda; Hiroko Hiraike; Hiroshi Ogura; Takeshi Shimazu
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

9.  High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.

Authors:  Yuji Nadatani; Toshio Watanabe; Tetsuya Tanigawa; Fumikazu Ohkawa; Shogo Takeda; Akira Higashimori; Mitsue Sogawa; Hirokazu Yamagami; Masatsugu Shiba; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Koji Takeuchi; Tetsuo Arakawa
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  Relationship between vascular reactivity and expression of HMGB1 in a rat model of septic aorta.

Authors:  Satoshi Nishiike; Toshiaki Hiramatsu; Miharu Shiraishi; Yoshimichi Ueda; Hideaki Tsuchida
Journal:  J Anesth       Date:  2013-03-27       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.